Price History
Apr 8, 2026 — May 15, 2026Investment Snapshot
- P/B of 3.99 — trading above book value
- Piotroski F-Score 1/9 — signs of financial weakness
- Loss-making — negative ROE of -89.5%
Satellos Bioscience Inc. - Common Stock (MSLE) is a Healthcare company operating in Biotechnology, listed on the NASDAQ , with a market capitalisation of $111 million . Key value metrics: P/B ratio 3.99, Piotroski F-Score 1 out of 9 .
Value Score
Key Metrics
Satellos Bioscience Inc. - Common Stock — Fundamental Analysis Summary
On financial health, MSLE shows a weak Piotroski F-Score of 1/9, a signal of deteriorating financial health, and negative return on equity of -89.5% (sector average: -20.6%).
StockPik's composite Value Score for MSLE is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MSLE shows earnings declining at 21%.